Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date
	Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non–Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2 Journal:The Oncologist	Finn, Richard S.Yau, ThomasHsu, Chih HungDe Toni, Enrico N.Goyal, LipikaGalle, Peter R.Qin, Shu KuiRao, SujataSun, FangfangWang, ChunxiaoWidau, Ryan C.Zhu, Andrew X.	9-Dec-2022
	Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial Journal:The Lancet Oncology	Kelley, Robin KateRimassa, LorenzaCheng, Ann LiiKaseb, AhmedQin, ShukuiZhu, Andrew X.Chan, Stephen L.Melkadze, TamarSukeepaisarnjaroen, WattanaBreder, ValeryVerset, GontranGane, EdwardBorbath, IvanRangel, Jose David GomezRyoo, Baek YeolMakharadze, TamtaMerle, PhilippeBenzaghou, FawziBanerjee, KamalikaHazra, SaswatiFawcett, JonathanYau, Thomas	1-Aug-2022
	A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors Journal:Journal of Experimental & Clinical Cancer Research	Chan, Stephen L.Schuler, MartinKang, Yoon KooYen, Chia JuiEdeline, JulienChoo, Su PinLin, Chia ChiOkusaka, TakujiWeiss, Karl HeinzMacarulla, TeresaCattan, StéphaneBlanc, Jean FredericLee, Kyung HunMaur, MichelaPant, ShubhamKudo, MasatoshiAssenat, EricZhu, Andrew X.Yau, ThomasLim, Ho YeongBruix, JordiGeier, AndreasGuillén-Ponce, CarmenFasolo, AngelicaFinn, Richard S.Fan, JiaVogel, ArndtQin, ShukuiRiester, MarkusKatsanou, VasilikiChaudhari, MonicaKakizume, TomoyukiGu, YiPorta, Diana GrausMyers, AndreaDelord, Jean Pierre	2-Jun-2022
	Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma Journal:Nature Medicine	Zhu, Andrew X.Abbas, Alexander R.de Galarreta, Marina RuizGuan, YinghuiLu, ShanKoeppen, HartmutZhang, WenjunHsu, Chih HungHe, Aiwu RuthRyoo, Baek YeolYau, ThomasKaseb, Ahmed O.Burgoyne, Adam M.Dayyani, FarshidSpahn, JessicaVerret, WendyFinn, Richard S.Toh, Han ChongLujambio, AmaiaWang, Yulei	23-Jun-2022
	Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma Journal:Journal of the National Cancer Institute	Kikuchi, HirotoMatsui, AyaMorita, SatoruAmoozgar, ZohrehInoue, KoetsuRuan, ZhipingStaiculescu, DanielWong, Jeffrey Sum LungHuang, PeigenYau, ThomasJain, Rakesh K.Duda, Dan G.	9-Sep-2022
	Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial Journal:The Lancet Oncology	Yau, ThomasPark, Joong WonFinn, Richard S.Cheng, Ann LiiMathurin, PhilippeEdeline, JulienKudo, MasatoshiHarding, James J.Merle, PhilippeRosmorduc, OlivierWyrwicz, LucjanSchott, EckartChoo, Su PinKelley, Robin KateSieghart, WolfgangAssenat, EricZaucha, RenataFuruse, JunjiAbou-Alfa, Ghassan K.El-Khoueiry, Anthony B.Melero, IgnacioBegic, DamirChen, GongNeely, JaclynWisniewski, TamiTschaika, MarinaSangro, Bruno	13-Dec-2021
	Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib Journal:European Journal of Cancer	Kudo, MasatoshiFinn, Richard S.Edeline, JulienCattan, StéphaneOgasawara, SadahisaPalmer, Daniel H.Verslype, ChrisZagonel, VittorinaFartoux, LaetitiaVogel, ArndtSarker, DebashisVerset, GontranChan, Stephen L.Knox, JenniferDaniele, BrunoYau, Chung Cheung ThomasGurary, Ellen B.Siegel, Abby B.Wang, AnranCheng, Ann LiiZhu, Andrew X.	19-Mar-2022
	Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study Journal:Liver Cancer	Sim, Yu KiChong, Ming ChuenGandhi, MihirPokharkar, Yogesh MahadevZhu, YananShi, LumingLequn, LiChen, Chien HungKudo, MasatoshiLee, Joon HyeokStrasser, Simone I.Chanwat, RawisakChow, Pierce K.H.Tse, EdmundStrasser, SimoneLequn, LiLi, JiangtaoJia, FanXu, ZhuBai, YuxianShu-Kui, QinYau, ThomasFuruse, JunjiShimada, KazuakiHasegawa, KiyoshiTakemura, NobuyukiBartlett, AdamChow, PierceLim, KieronSeng, Tan PohYoung, Dan YockGoh, BrianYoon, Hyun KiHwan, Kim YunSungbum, ChoLee, Joon HyeokHan, Ho SeongJin-Mo, YangYoung, Choi JongWang, Hee JungKim, Do YoungHospital, SeveranceYuan, Peng ChengChao, YeeHu, Tsung HuiCheng, Pin NanChen, Chien HungChanwat, RawisakNimanong, Supot	9-Oct-2023
	Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial Journal:The Lancet	Yau, ThomasGalle, Peter R.Decaens, ThomasSangro, BrunoQin, Shukuida Fonseca, Leonardo G.Karachiwala, HatimBlanc, Jean FredericPark, Joong WonGane, EdwardPinter, MatthiasPeña, Ana MatillaIkeda, MasafumiTai, DavidSantoro, ArmandoPizarro, GonzaloChiu, Chang FangSchenker, MichaelHe, AiwuChon, Hong JaeWojcik-Tomaszewska, JoannaVerset, GontranWang, Qi QiStromko, CaitlynNeely, JaclynSingh, PriankaJimenez Exposito, Maria JesusKudo, Masatoshi	24-May-2025
	Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial Journal:The Lancet Gastroenterology & Hepatology	Chia, John W.K.Segelov, EvaDeng, YanhongHo, Gwo FuangWang, WeiHan, ShutingSharma, AtulDing, KefengChen, GongJeffery, Mark G.Tham, Chee KianAhn, Joong BaeNott, LouiseZielinski, RobertChao, Tsu Yivan Hagen, TomWei, Po LiDay, FionaMehta, ShaestaYau, ThomasPeng, JiewenHayes, Theresa M.Li, YongGandhi, MihirFoo, Estelle M.J.Rahman, NabilahRothwell, PeterAli, RaghibSimes, JohnToh, Han Chong	1-Mar-2025
	Trifluridine/Tipiracil (FTD/TPI) in Metastatic Colorectal Cancer in Hong Kong: A Territory-Wide Cohort Study Journal:Advances in Therapy	Lam, Ka OnLi, Karen Hoi LamLeung, Roland Ching YuTang, VikkiYau, Thomas	13-Jan-2025
	APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 Journal:Hepatology International	Lau, GeorgeObi, ShuntaroZhou, JianTateishi, RyosukeQin, ShukuiZhao, HaitaoOtsuka, MotoyukiOgasawara, SadahisaGeorge, JacobChow, Pierce K.H.Cai, JianqiangShiina, ShuichiroKato, NaoyaYokosuka, OsamuOura, KyokoYau, ThomasChan, Stephen L.Kuang, MingUeno, YoshiyukiChen, MinshanCheng, Ann LiiCheng, GregoryChuang, Wan LongBaatarkhuu, OidovBi, FengDan, Yock YoungGani, Rino A.Tanaka, AtsushiJafri, WasimJia, Ji DongKao, Jia HorngHasegawa, KiyoshiLau, PatrickLee, Jeong MinLiang, JunLiu, ZhenwenLu, YinyingPan, HongmingPayawal, Diana A.Rahman, SalimurSeong, JinsilShen, FengShiha, GamalSong, TianqiangSun, Hui ChuanMasaki, TsutomuSirachainan, EkaphopWei, LaiYang, Jin MoSallano, Jose D.Zhang, YanqiaoTanwandee, TawesakDokmeci, AKadirZheng, Shu SenFan, JiaFan, Sheung TatSarin, Shiv KumarOmata, Masao	1-Dec-2024
	Dual CTLA-4 and PD-1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first-in-human, dose-escalation, and dose-expansion study Journal:Cancer	Bishnoi, SarwanKotasek, DusanAghmesheh, MortezaYau, ThomasCosman, RashaPrawira, AmyMoore, MaggieChan, Stephen LMant, AndrewEek, RichardZielinski, RobertSu, RilaPan, ZhaoxuanMa, YidingLi, FeiLi, PeiqiTse, Archie N	1-Jun-2024
	Embracing the setting sun: Provision of palliative care via a collaborative model between hospital and community for patients with intellectual disabilities Journal:Annals of Palliative Medicine	Li, Cho WingWong, Yuk ChunLo, Yiu ManSham, Mau KwongCheng, Hon WaiLai, TheresaLau, Wai KeeChan, Kwok Ying	2018
	Supportive care and symptom management in patients with advanced hematological malignancies: a literature review Journal:Annals of Palliative Medicine	Chan, Kwok YingChan, Thomas Sau YanGill, HarinderChan, Timmy Chi WingLi, Cho WingAu, Ho YanWong, Chi YanTsang, Kwok WaiLo, Raymond See KitCheng, Benjamin Hon WaiHui, Chun HimMok, Lesley Wan SzeKwok, Cecilia Sze LaiChan, Man LuiSham, Mau Kwong	2022
	Perspective of palliative care in radiation-oncology Journal:Annals of Palliative Medicine	Chan, Kwok YingGill, HarinderLi, Cho WingAu, Ho YanWong, Chi YanChan, Man Lui	2022
	Combination therapy with low-dose metolazone and furosemide: a "needleless" approach in managing refractory fluid overload in elderly renal failure patients under palliative care Journal:International urology and nephrology	Cheng, Hon W.ai BenjaminSham, Mau KwongChan, Kwok YingLi, Cho WingAu, Ho YanYip, Terence	2014
	Intensive Palliative Care for Patients With Hematological Cancer Dying in Hospice: Analysis of the Level of Medical Care in the Final Week of Life Journal:American Journal of Hospice and Palliative Medicine	Cheng, Benjamin Hon WaiSham, Michael Mau KwongChan, Kwok YingLi, Cho WingAu, Ho Yan	2015
	End-of-life characteristics and palliative care provision for elderly patients suffering from acute myeloid leukemia Journal:Supportive Care in Cancer	Cheng, Hon Wai BenjaminLi, Cho WingChan, Kwok YingAu, Ho YanChan, Pan FongSin, Yim ChingSzeto, YanSham, Mau Kwong	2015
	Bringing palliative care into geriatrics in a Chinese Culture Society - Results of a collaborative model between palliative medicine and geriatrics unit in Hong Kong Journal:Journal of the American Geriatrics Society	Cheng, Hon Wai BenjaminLi, Cho WingChan, Kwok YingHo, RebeccaSham, Mau Kwong	2014